Showing results (11-20 of 234) with videos related to
Sort By:
Pageof 24
Seminars in Radiation Oncology|May 3, 2003
Chemotherapy for localized, high-risk prostate cancerSamir Narayan, David C Smith, Howard M SandlerSeminars in Oncology|August 9, 2003
Combined modality treatment for prostate cancer: role of chemotherapyHoward M Sandler, Samir Narayan, David C SmithJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 31, 2016
Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After ProstatectomyZachary S Zumsteg, Timothy J Daskivich, Howard M SandlerJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2005
Individualized predictions of disease progression following radiation therapy for prostate cancerJeremy M G Taylor, Menggang Yu, Howard M SandlerJournal of Contemporary Brachytherapy|September 6, 2021
High-dose-rate fractionated brachytherapy monotherapy for localized prostate cancer: a systematic review and meta-analysisEric M Anderson, Sungjin Kim, Howard M Sandler, et al.The Journal of Urology|January 22, 2008
The impact of treatment choice for localized prostate cancer on response to phosphodiesterase inhibitorsIrwin H Lee, Natalia Sadetsky, Peter R Carroll, et al.Urology|August 30, 2008
No effect of statins on biochemical outcomes after radiotherapy for localized prostate cancerDaniel E Soto, Stephanie Daignault, Howard M Sandler, et al.International Journal of Radiation Oncology, Biology, Physics|May 10, 2011
Concurrent androgen deprivation therapy during salvage prostate radiotherapy improves treatment outcomes in high-risk patientsDaniel E Soto, Michael N Passarelli, Stephanie Daignault, et al.Brachytherapy|January 23, 2020
A dosimetric evaluation of a single urethral constraint for high-dose-rate prostate brachytherapyDiana J Lu, Tiffany Phillips, John DeMarco, et al.International Journal of Radiation Oncology, Biology, Physics|January 17, 2009
Evaluating the relationships between rectal normal tissue complication probability and the portion of seminal vesicles included in the clinical target volume in intensity-modulated radiotherapy for prostate cancerIris Gluck, Karen A Vineberg, Randall K Ten Haken, et al.Pageof 24